NMPA Announcement on the Issuance of Two Supplementary Testing Methods for Cosmetics, Including Determination of Diclofenac Sodium in Cosmetics
Aug 3
1 min read
Updated: Sep 22

In accordance with the Regulations on the Supervision and Administration of Cosmetics, the National Medical Products Administration (NMPA) has approved two supplementary testing methods for cosmetics, namely Determination of Diclofenac Sodium in Cosmetics and Determination of Hexamethylenetetramine in Cosmetics, which are hereby issued.
This announcement is hereby issued.
Annex1:Determination of Diclofenac Sodium in Cosmetics (BJH 202601)
Annex2:Determination of Hexamethylenetetramine in Cosmetics (BJH 202602)



Comments